本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Solid Biosciences

2.55
+0.03001.19%
盤後2.50-0.0499-1.96%19:05 EDT
成交量:154.20萬
成交額:388.26萬
市值:1.98億
市盈率:-0.83
高:2.61
開:2.53
低:2.45
收:2.52
資料載入中...
2022/12/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/12/06

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/05

重要事件披露

8-K - Current report
2022/12/05

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/05

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/02

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/12/01

重要事件披露

8-K - Current report
2022/11/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/10/27

重要事件披露

8-K - Current report
2022/10/04

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/10/03

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/30

重要事件披露

8-K - Current report
2022/09/30

重要事件披露

8-K - Current report
2022/09/06

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/02

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/01

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/08/18

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/11

重要事件披露

8-K - Current report
2022/06/09

重要事件披露

8-K - Current report